Medical device steriliser Nanosonics is pushing for stronger sales of its flagship device Trophon, ahead of the release of an ...

The two women are scheduled to have the kidney transplant procedure done on Thursday at Tampa General Hospital. TGH says it ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $33.62, along ...

By adopting FDA-endorsed endpoints that are easier to achieve, Dimerix has bolstered the chances of its pivotal kidney drug trial succeeding.

Chronic kidney disease (CKD) is typically associated with severe fibrosis, the exact pathogenesis of which remains unclear.

Armistice Capital holds 8.9M shares in Travere Therapeutics as rare kidney disease stock climbs 110% following FILSPARI's ...

Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney disease addressing renal lipotoxicity.There are no available drug ...

Two weeks ago, Travere unveiled the Play It Forward campaign. The awareness push features the aptly named Feel So Good Song, an anthem penned by Grammy-winning musician Brian Kennedy and ...

Travere Therapeutics Inc. (NASDAQ: TVTX) is one of the best biotech stocks to invest in now. On June 10, Travere Therapeutics launched a new awareness campaign called ‘Play It Forward’ to support the ...

Diagnosed with focal segmental glomerulosclerosis (FSGS), a rare disease that damages kidney filters, Andrews faced the end of his football dreams and the start of a daunting medical journey.

Abstract Background. Focal and segmental glomerulosclerosis (FSGS) is the most common histologic pattern of renal injury seen in adults with idiopathic proteinuria. Homozygous or compound ...

Focal segmental glomerulosclerosis (FSGS) still lacks an FDA-approved therapy, but late-breaking post hoc results from the phase III DUPLEX trial -- presented at the National Kidney Foundation ...